Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of AtriCure (NASDAQ:ATRC) through any online brokerage.
Other companies in AtriCure’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
AtriCure has a consensus price target of $54.15.
The stock price for AtriCure (NASDAQ: ATRC) is $55.15 last updated October 2, 2026 at 6:53 PM EDT.
There are no upcoming dividends for AtriCure.
AtriCure does not have any upcoming earnings scheduled.
There is no upcoming split for AtriCure.
AtriCure is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.